REFERENCES

1. Bourne MS, Williams GE. Compression of the inferior vena cava by hydatid disease of the liver with associated hepatocellular carcinoma. Gastroenterology 1963;45:667-9.

2. Perrone-Donnorso R. Double peritoneal dissemination of hydatidosis and concomitant hepatocellular carcinoma. Riv Anat Patol Oncol 1969;35:266-80. (in Italian)

3. Zöld E, Barta Z, Zeher M. Hydatid disease of the liver and associated hepatocellular carcinoma. Clin Gastroenterol Hepatol 2005;3:xxxv.

4. Kato T, Seino Y, Takada K, Maruya M, Okubo S, Nakamura H, Inoue Y, Meguro T, Horita S, Oshikiri T, Yamada H, Miyasaka Y, Fujita M, Morita T, Yoshida T, Chikai K. A resectable case of hepatocellular carcinoma complicated with hepatic alveolar echinococcosis. Nihon Shokakibyo Gakkai Zasshi 2003;100:587-92. (in Japanese)

5. Kostov D, Dragnev N, Patanov R, Kobakov G. Hepatocellular carcinoma complicated with echinococcal cyst of the liver. Khirurgiia (Sofiia) 2010;(4-5):49-50. (in Bulgarian)

6. Kübeck M, Stöckl V, Stainer W, Schermaier T, Preisinger J, Schauer W, Hochleitner U, Höbling W, Barth TF, Stadler B, Knoflach P, Kirchgatterer A. Cystic echinococcosis and hepatocellular carcinoma – a coincidence? A case report. Z Gastroenterol 2014;52:657-62. (in German)

7. Hoffmann T, Schlensak M, Erhard J, Trenn G. Echinococcosis – A rare differential diagnosis of a tumorous hepatic lesion. Z Gastroenterol 2003;41:913-6. (in German)

8. Kohlenberg A, Wüsten O, Dierkes C, Discher T, Tappe D. Education and Imaging. Hepatobiliary and pancreatic: alveolar echinococcosis mimicking hepatocellular carcinoma. J Gastroenterol Hepatol 2010;25:1712.

9. Stoianov G, Iarŭmov N, Damianov N, Ilieva IU. Liver cirrhosis caused by liver echinococcosis. Khirurgiia (Sofiia) 2006;(3):20-2. (in Bulgarian)

10. Mas-Coma S, Valero MA, Bargues MD. Fascioliasis. Adv Exp Med Biol 2014;766:77-114.

11. Vítovec J. Hepatocellular carcinoma in cattle and its relationship to biliary cirrhosis of fasciolar origin. Vet Pathol 1974;11:548-57. (in German)

12. Kabaalioglu A, Ceken K, Alimoglu E, Saba R, Cubuk M, Arslan G, Apaydin A. Hepatobiliary fascioliasis: sonographic and CT findings in 87 patients during the initial phase and long-term follow-up. AJR Am J Roentgenol 2007;189:824-8.

13. Kim YI. Liver carcinoma and liver fluke infection. Arzneimittelforschung 1984;34:1121-6.

14. Sonakul D, Koompirochana C, Chinda K, Stitnimakarn T. Hepatic carcinoma with opisthorchiasis. Southeast Asian J Trop Med Public Health 1978;9:215-9.

15. Srivatanakul P, Parkin DM, Jiang YZ, Khlat M, Kao-Ian UT, Sontipong S, Wild C. The role of infection by Opisthorchis viverrini, hepatitis B virus, and aflatoxin exposure in the etiology of liver cancer in Thailand. A correlation study. Cancer 1991;68:2411-7.

16. Suksumek N, Leelawat K, Leelawat S, Russell B, Lek-Uthai U. TaqMan real-time PCR assay for specific detection of Opisthorchis viverrini DNA in Thai patients with hepatocellular carcinoma and cholangiocarcinoma. Exp Parasitol 2008;119:217-24.

17. Purtilo DT. Clonorchiasis and hepatic neoplasms. Trop Geogr Med 1976;28:21-7.

18. Nakashima T, Sakamoto K, Okuda K. A minute hepatocellular carcinoma found in a liver with clonorchis sinensis infection: report of two cases. Cancer 1977;39:1306-11.

19. Tan SK, Qiu XQ, Yu HP, Zeng XY, Zhao YN, Hu L. Evaluation of the risk of clonorchiasis inducing primary hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi 2008;16:114-6. (in Chinese)

20. Chen X, Li S, He L, Wang X, Liang P, Chen W, Bian M, Ren M, Lin J, Liang C, Xu J, Wu Z, Li X, Huang Y, Yu X. Molecular characterization of severin from Clonorchis sinensis excretory/secretory products and its potential anti-apoptotic role in hepatocarcinoma PLC cells. PLoS Negl Trop Dis 2013;7:e2606.

21. Domingo EO, Warren KS, Stenger RJ. Increased incidence of hepatoma in mice with chronic schistosomiasis mansoni treated with a carcinogen. Am J Pathol 1967;51:307-21.

22. Abe K, Kagei N, Teramura Y, Ejima H. Hepatocellular carcinoma associated with chronic Schistosoma mansoni infection in a chimpanzee. J Med Primatol 1993;22:237-9.

23. Edington GM. Schistosomiasis and primary liver cell carcinoma. Trans R Soc Trop Med Hyg 1979;73:351.

24. Nakashima T, Okuda K, Kojiro M, Sakamoto K, Kubo Y. Primary liver cancer coincident with Schistosomiasis japonica. A study of 24 necropsies. Cancer 1975;36:1483-9.

25. Fujimoto H, Araki T, Hihara T, Karikomi M, Kachi K, Saito Y, Hayashi S, Uchiyama G. Hepatocellular carcinoma associated with Schistosomiasis japonica; CT and angiographic features. Nihon Igaku Hoshasen Gakkai Zasshi 1989;49:139-45. (in Japanese)

26. Khella AK, Faris L, Helmy S, Yousif A, Esmail S. A hospital based case-control study of hepatocellular carcinoma. J Egypt Public Health Assoc 1992;67:249-58.

27. Abdel-Hamid NM. Recent insights on risk factors of hepatocellular carcinoma. World J Hepatol 2009;1:3-7.

28. Li ZJ, Luo DD, Dai JZ, Zheng LL, Wang XH, Liu SC, Shong GF, Yang YX, Wang HC. Immunohistochemical detection of HBsAg and HBcAg in the liver of patients with Schistosomiasis japonica complicated by hepatocellular carcinoma. J Tongji Med Univ 1991;11:141-4.

29. Uetsuji S, Yamamura M, Okuda Y, Yamamichi K, Yamamoto M. Primary liver cancer coincident with Schistosomiasis japonica. Gan No Rinsho 1990;36:521-5. (in Japanese)

30. Badawi AF, Michael MS. Risk factors for hepatocellular carcinoma in Egypt: the role of hepatitis-B viral infection and schistosomiasis. Anticancer Res 1999;19:4565-9.

31. el-Zayadi AR, Badran HM, Barakat EM, Attia Mel-D, Shawky S, Mohamed MK, Selim O, Saeid A. Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol 2005;11:5193-8.

32. Nakashima T, Kage M, Hirata M. A historical view of Schistosomiasis japonica in the Chikugo river basin. What can we learn from autopsy? Parasitol Int 2003;52:327-34.

33. Yosry A. Schistosomiasis and neoplasia. Contrib Microbiol 2006;13:81-100.

34. El-Tonsy MM, Hussein HM, Helal Tel-S, Tawfik RA, Koriem KM, Hussein HM. Schistosoma mansoni infection: is it a risk factor for development of hepatocellular carcinoma? Acta Trop 2013;128:542-7.

35. Attallah AM, Tabll AA, El-Nashar E, El-Bakry KA, El-Sadany M, Ibrahim T, El-Dosoky I. AgNORs count and DNA ploidy in liver biopsies from patients with schistosomal liver cirrhosis and hepatocellular carcinoma. Clin Biochem 2009;42:1616-20.

36. Attallah AM, Tabll AA, El-Sadany M, Ibrahim TA, El-Dosoky I. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma. Clin Exp Med 2003;3:181-5.

37. McGarvey ST, Aligui G, Graham KK, Peters P, Olds GR, Olveda R. Schistosomiasis japonica and childhood nutritional status in northeastern Leyte, the Philippines: a randomized trial of praziquantel versus placebo. Am J Trop Med Hygvz 1996;54:498-502.

38. Wahib AA, Masoud AA, Halem AA, Haseeb AN, Hassan AR, Darwish MA, Hegazi M, Abdallah KF. Cell mediated immune response in chronic liver diseases: schistosomal, viral and neoplastic. J Egypt Soc Parasitol 1998;28:929-39.